A Safety, Efficacy and Tolerability Study of SEP-225289
Public ClinicalTrials.gov record NCT00584974. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled Study Examining The Safety, Efficacy, and Tolerability of SEP-225289 in Subjects With Major Depressive Disorder (Including Atypical and Melancholic Features)
Study identification
- NCT ID
- NCT00584974
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Enrollment
- 523 participants
Conditions and interventions
Conditions
Interventions
- SEP-225289 Drug
- Venlafaxine Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2007
- Primary completion
- Apr 30, 2009
- Completion
- Apr 30, 2009
- Last update posted
- Feb 22, 2012
2007 – 2009
United States locations
- U.S. sites
- 51
- U.S. states
- 22
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72211 | — |
| Not listed | Arcadia | California | 91007 | — |
| Not listed | Beverly Hills | California | 90210 | — |
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Garden Grove | California | 92845 | — |
| Not listed | Glendale | California | 91204 | — |
| Not listed | Irvine | California | 92618 | — |
| Not listed | Lafayette | California | 94549 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Upland | California | 91786 | — |
| Not listed | Denver | Colorado | 80204 | — |
| Not listed | Denver | Colorado | 80239 | — |
| Not listed | New Britain | Connecticut | 06050 | — |
| Not listed | Bradenton | Florida | 34208 | — |
| Not listed | Fort Myers | Florida | 33912 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Lauderhill | Florida | 33139 | — |
| Not listed | Maitland | Florida | 32751 | — |
| Not listed | North Miami | Florida | 33161 | — |
| Not listed | Sanford | Florida | 32771 | — |
| Not listed | Atlanta | Georgia | 30328 | — |
| Not listed | Atlanta | Georgia | 30341 | — |
| Not listed | Smyrna | Georgia | 30080 | — |
| Not listed | Park Ridge | Illinois | 60068 | — |
| Not listed | Lake Charles | Louisiana | 70601 | — |
| Not listed | Boston | Massachusetts | 02135 | — |
| Not listed | Braintree | Massachusetts | 02184 | — |
| Not listed | Flowood | Mississippi | 39232 | — |
| Not listed | Saint Charles | Missouri | 63301 | — |
| Not listed | Clementon | New Jersey | 08021 | — |
| Not listed | Albuquerque | New Mexico | 87109 | — |
| Not listed | Brooklyn | New York | 11235 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | New York | New York | 10023 | — |
| Not listed | New York | New York | 10075 | — |
| Not listed | The Bronx | New York | 10454 | — |
| Not listed | The Bronx | New York | 10467 | — |
| Not listed | Raleigh | North Carolina | 27609 | — |
| Not listed | Cincinnati | Ohio | 45227 | — |
| Not listed | Dayton | Ohio | 45408 | — |
| Not listed | Middleburg Heights | Ohio | 44130 | — |
| Not listed | Oklahoma City | Oklahoma | 73112 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Philadelphia | Pennsylvania | 19149 | — |
| Not listed | Austin | Texas | 78756 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Houston | Texas | 77040 | — |
| Not listed | Irving | Texas | 75062 | — |
| Not listed | Midlothian | Virginia | 23112 | — |
| Not listed | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00584974, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00584974 live on ClinicalTrials.gov.